When was Clear Labs founded?

Clear Labs was founded in 2014 and raised its 1st funding round within a year of its incorporation.

Where is Clear Labs located?

Clear Labs is headquartered in Menlo Park, United States. It is registered at San Carlos, California.

Who is the current CEO of Clear Labs?

Sasan Amini and Mahni Ghorashi s of Clear Labs. Sasan Amini has also founded 1 company.

How many employees does Clear Labs have?

As of Jun 30, 2026, the latest employee count at Clear Labs is 85.

Is Clear Labs a funded company?

Clear Labs is a funded company, having raised a total of $171M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 02, 2014.

When was the latest funding round of Clear Labs?

Clear Labs' latest funding was a $***** Series D round on Dec 12, 2024, with participation from 10 investors.

Where does Clear Labs rank among its competitors?

Clear Labs ranks 10th amongst 407 active competitors, of which 97 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Daye, which secured $576K in Nov, 2025.

Who are the top competitors of Clear Labs?

Clear Labs' top competitors include Adaptive Biotechnologies, MeMed and OpGen. Among them, Daye secured the most recent funding round in November, 2025.

Clear Labs - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of food safety technologies for the identification of pathogens. The company offers Clear Dx, a rapid, high throughput next-generation sequencing (NGS) platform for clinical and public health labs that offers a complete characterization of SARS-CoV-2.

Website: www.clearlabs.com/
Social
Registered Address: San Carlos, California

Key Metrics

Founded Year

2014

Location

Menlo Park, United States

Stage

Series D

Total Funding

$171M in 9 rounds

Latest Funding Round

Series D, Dec 12, 2024, $*****

Investors

Menlo Ventures & 27 more

Ranked

10^th among 407 active competitors

Employee Count

85 as on Jun 30, 2026

Similar Companies

Adaptive Biotechnologies & 491 more

View Clear Labs' full profile

Clear Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Clear Labs, Inc. CIN: 463655012 , United States, Active	Dec 26, 999	-	55 (As on Dec 31, 2019)	-

Clear Labs has raised a total funding of $171M over 9 rounds. Its first funding round was on Jan 02, 2014. Its latest funding round was a Series D round on Dec 12, 2024 for $*****. 10 investors participated in its latest round. Clear Labs has 28 institutional investors.

Here is the list of recent funding rounds of Clear Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 12, 2024	3514938	Series D	3937586	3425871	3465740	2854654
May 26, 2021	1437270	Series C	6040296	1824218	3187859	Redmile Group & 7 more
May 18, 2020	6324458	Series B	9088306	4527474	Google Ventures & 3 more	6526227

Access funding benchmarks and valuations. Sign up today!

View details of Clear Labs's funding rounds and investors

The founders of Clear Labs are Sasan Amini and Mahni Ghorashi. Sasan Amini is the CEO of Clear Labs.

Here are the details of Clear Labs' key team members:

Sasan Amini: Co-Founder & CEO of Clear Labs and founder of 1 other company.
Contact Info: 1 email address
Mahni Ghorashi: Co-Founder & CEO of Clear Labs.

View details of Clear Labs's Founder profiles and Board Members

Clear Labs' employee count trend

Clear Labs has 85 employees as of Jun 26. Here is Clear Labs's employee count trend over the years:

Uncover Clear Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Clear Labs include Adaptive Biotechnologies, MeMed and OpGen. Here is the list of Top 10 competitors of Clear Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	77/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	OpGen 2002, Rockville (United States), Public	Developer of diagnostics and bioinformatics platforms for providers	$77.5M	Cross Creek, 180 Degree Capital & 12 others	67/100
4th	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	STRIVE, Sun Pharma & 32 others	67/100
5th	Daye 2018, London (United Kingdom), Series A	Manufacturer of period care products and provider of health tests	$19.2M	Khosla Ventures, Salica Investments & 24 others	60/100
6th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
7th	Oncimmune 2006, Cambridge (United States), Acquired	Immunodiagnostics company developing biomarker platforms for cancer and immune diseases	-	IPF Partners, Balderton Capital & 9 others	58/100
8th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Gilde Healthcare & 16 others	58/100
9th	PathoQuest 2010, Paris (France), Acquired	Provider of next-generation sequencing for microbiology testing	$9.99M	Kurma Partners, Charles River Laboratories ... & 9 others	57/100
10th	Clear Labs 2014, Menlo Park (United States), Series D	Provider of food safety technologies for the identification of pathogens	$171M	T. Rowe Price, Google Ventures & 26 others	57/100